Small Cell Lung Cancer News and Research

RSS

Small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. Small cell lung cancer is an aggressive (fast-growing) cancer that can spread to other parts of the body. The cancer cells look small and oval-shaped when looked at under a microscope.

Radiation therapy cures lung cancer

According to the Global Lung Cancer Coalition, each year ten million people are diagnosed with lung cancer, and half of all patients die within a year of diagnosis.

24 Jan 2006

Palliative radiation cures some lung cancer patients

About one in a hundred patients with apparently incurable non-small cell lung cancer (NSCLC) survive five or more years after being given relatively small doses of radiation therapy (RT) meant to ease symptoms, according to a new study.

23 Jan 2006

TCF21 gene shown to be a tumor suppressor

Researchers have identified a new and unusual tumor suppressor gene that may be important in cancers of the lung and head and neck. The study shows that restoring the inactivated gene can slow the growth of tumor cells.

18 Jan 2006

Bexarotene shows promise in cancer treatment.

Researchers at Washington University School of Medicine in St. Louis now report that a compound related to vitamin A shows promise in preventing or slowing tumor growth in mice prone to lung cancer. The compound, called bexarotene, doesn't cause the severe skin irritations that have limited the use of other vitamin A derivatives in cancer therapies.

18 Jan 2006

Caspase 8 gene halts spread of aggressive childhood cancer

A team of cancer researchers has shown that a gene commonly lost during neuroblastoma tumor formation, one of the most aggressive cancers in babies and children, is in fact a "metastasis suppressor" gene.

6 Jan 2006

Targeted cancer therapies: Another step forward

While it is clear that the treatment of cancer has already begun to undergo a paradigm shift with the inclusion of innovative targeted therapies into current regimens, it would be wrong to assume these products will entirely replace traditional chemotherapy as the standard treatment for cancer sufferers.

22 Dec 2005

Targeted cancer therapies: Another step forward

22 Dec 2005

New and promising antibody profiling technique to test for non-small cell lung cancer cases

Biomedical scientists have revealed a new and promising antibody profiling technique that provides a high degree of early diagnostic accuracy for non-small cell lung cancer cases.

26 Nov 2005

Race may play a role in whether a patient accepts surgical treatment for lung cancer

A study in the November issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), found that blacks with lung cancer declined surgery at a higher rate than whites

14 Nov 2005

Women show a better response to lung cancer therapy, resulting in better survival rates

However, in untreated patients, women also had a 21 percent decreased risk of death as compared with men, leading researchers to believe lung cancer in women has a different biologic behavior and natural history than in men.

3 Nov 2005

Stereotactic body radiation therapy safe and effective way to treat early stage lung cancer in medically inoperable patients

Lung cancer patients with extenuating health problems may have an alternative to traditional radiation therapy through a lung-sparing procedure pioneered at the Indiana University School of Medicine.

1 Nov 2005

Gene therapy may prevent the damaging effects of radiation

Gene therapy could be used as an agent to protect normal tissues, including the esophagus and lung, from damage during a second administration of radiation therapy for non-small cell lung cancer, according to an animal study presented by University of Pittsburgh researchers at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Denver.

16 Oct 2005

Americans' risk of dying from cancer continues to decline

The nation's leading cancer organizations report that Americans' risk of dying from cancer continues to decline and that the rate of new cancers is holding steady. The "Annual Report to the Nation on the Status of Cancer, 1975-2002," published in the Oct. 5, 2005, issue of the Journal of the National Cancer Institute, shows observed cancer death rates from all cancers combined dropped 1.1 percent per year from 1993 to 2002.

4 Oct 2005

Tarceva should be tested as front-line therapy for older lung cancer patients

The tyrosine kinase inhibitor erlotinib (Tarceva) showed encouraging activity with relatively tolerable side effects in elderly, previously untreated patients with advanced non-small cell lung cancer (NSCLC), reports a team led by investigators from Dana-Farber Cancer Institute in Boston.

19 Sep 2005

Giving patients both chemotherapy and radiation in the beginning of treatment may help cancer patients live longer

While researchers have learned in the last decade that combining chemotherapy with radiation is better than radiation alone for treating non-small cell lung cancer patients with locally advanced disease - cancer confined to the lungs - finding the right combination of drugs - and the best timing of treatment - has been tricky.

6 Sep 2005

Toxicity from chemotherapy in lung cancer patients could help predict treatment efficacy

Chemotherapy is standard treatment for patients with advanced non-small cell lung cancer, although benefits are modest and toxicity substantial. Massimo Di Maio and colleagues hypothesised that neutropenia, a haematological toxicity, could be a predictor of drug activity and treatment efficacy.

30 Aug 2005

Small Cell Lung Cancer News and Research

Radiation therapy cures lung cancer

Palliative radiation cures some lung cancer patients

TCF21 gene shown to be a tumor suppressor

Bexarotene shows promise in cancer treatment.

Caspase 8 gene halts spread of aggressive childhood cancer

Targeted cancer therapies: Another step forward

Targeted cancer therapies: Another step forward

New and promising antibody profiling technique to test for non-small cell lung cancer cases

Race may play a role in whether a patient accepts surgical treatment for lung cancer

Women show a better response to lung cancer therapy, resulting in better survival rates

Stereotactic body radiation therapy safe and effective way to treat early stage lung cancer in medically inoperable patients

Gene therapy may prevent the damaging effects of radiation

Americans' risk of dying from cancer continues to decline

Tarceva should be tested as front-line therapy for older lung cancer patients

Giving patients both chemotherapy and radiation in the beginning of treatment may help cancer patients live longer

Toxicity from chemotherapy in lung cancer patients could help predict treatment efficacy

Lorus identifies novel class of lead drug candidates from small molecule anticancer program

A preoperative testing strategy may help determine stage of lung cancer more accurately

Mutations in the targets of designer drugs critically influence their effectiveness

Introgen announces additional broad patent in China

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News